Gabapentin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Gabapentin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GABAPENTIN DESCRIPTION




Gabapentin



CLINICAL PHARMACOLOGY

Mechanism of Action





PHARMACOKINETICS AND DRUG METABOLISM





Special Populations: Adult Patients With Renal Insufficiency
DOSAGE AND ADMINISTRATION, Table 6

DOSAGE AND ADMINISTRATION

DOSAGE AND ADMINISTRATION

PRECAUTIONS, Geriatric UseDOSAGE AND ADMINISTRATION



DOSAGE AND ADMINISTRATION



CLINICAL STUDIES

Postherpetic Neuralgia:





Gabapentin


Gabapentin



Gabapentin



Epilepsy:








Gabapentin







INDICATIONS & USAGE

Postherpetic Neuralgia


Epilepsy


GABAPENTIN CONTRAINDICATIONS



WARNINGS

Suicidal Behavior and Ideation









Neuropsychiatric Adverse EventsPediatric Patients 3 to 12 years of age



Withdrawal Precipitated Seizure, Status Epilepticus



Tumorigenic Potential
PRECAUTIONS: Carcinogenesis, Mutagenesis, Impairment of Fertility


Sudden and Unexplained Death in Patients With Epilepsy



PRECAUTIONS

Information for Patients



Drug Interactions
PRECAUTIONS, Pregnancy

LABORATORY TESTS



DRUG INTERACTIONS










PRECAUTIONS





DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY






PREGNANCY






NURSING MOTHERS



PEDIATRIC USE


CLINICAL PHARMACOLOGYClinical Studies

GERIATRIC USE



CLINICAL PHARMACOLOGYADVERSE REACTIONSDOSAGE AND ADMINISTRATION

GABAPENTIN ADVERSE REACTIONS

Postherpetic Neuralgia



Incidence in Controlled Clinical Trials





Epilepsy:
WARNINGS, Neuropsychiatric Adverse Events


Incidence in Controlled Clinical Trials:










Other Adverse Events Observed During All Clinical Trials:















Clinical Trials in Pediatric Patients With Epilepsy:























Postmarketing and Other Experience



DRUG ABUSE AND DEPENDENCE



OVERDOSAGE





DOSAGE & ADMINISTRATION



Postherpetic Neuralgia


Epilepsy


CLINICAL PHARMACOLOGY, Pediatrics



Dosage in Renal Impairment









Dosage in Elderly


HOW SUPPLIED














SPL MEDGUIDE










  • ●     thoughts about suicide or dying
  • ●     attempts to commit suicide
  • ●     new or worse depression
  • ●     new or worse anxiety
  • ●     feeling agitated or restless
  • ●     panic attacks
  • ●     trouble sleeping (insomnia)
  • ●     new or worse irritability
  • ●     acting aggressive, being angry, or violent
  • ●     acting on dangerous impulses
  • ●     an extreme increase in activity and talking (mania)
  • ●     other unusual changes in behavior or mood

  • ●     Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings.
  • ●     Keep all follow-up visits with your healthcare provider as scheduled.


  • ●     Stopping gabapentin suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).




  • ●     Pain from damaged nerves (postherpetic pain) that follows healing of shingles (a painful rash that comes after a herpes zoster infection) in adults.
  • ●     Partial seizures when taken together with other medicines in adults and children 3 years of age and older.




  • ●     have or have had kidney problems or are on hemodialysis
  • ●     have or have had depression, mood problems, or suicidal thoughts or behavior
  • ●     are pregnant or plan to become pregnant. It is not known if gabapentin can harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking gabapentin. You and your healthcare provider will decide if you should take gabapentin while you are pregnant.
  • ●     If you become pregnant while taking gabapentin, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. You can enroll in this registry by calling 1-888-233-2334.
  • ●     are breast-feeding or plan to breast-feed. Gabapentin can pass into breast milk. You and your healthcare provider should decide how you will feed your baby while you take gabapentin.




  • ●     Take gabapentin exactly as prescribed. Your healthcare provider will tell you how much gabapentin to take.
  • ●     Do not change your dose of gabapentin without talking to your healthcare provider. If you break a tablet in half the unused half of the tablet should be taken at your next scheduled dose. Half tablets not used within several days of breaking should be thrown away.
  • ●     Gabapentin can be taken with or without food. If you take an antacid containing aluminum and magnesium, such as MaaloxMylantaGelusilGavisconor Di-Gelyou should wait at least 2 hours before taking your next dose of gabapentin.
  • ●     If you take too much gabapentin, call your healthcare provider or your local Poison Control Center right away.

  • ●     Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking gabapentin without first talking with your healthcare provider. Taking gabapentin with alcohol or drugs that cause sleepiness or dizziness may make your sleepiness or dizziness worse.
  • ●     Do not drive, operate heavy machinery, or do other dangerous activities until you know how gabapentin affects you. Gabapentin can slow your thinking and motor skills.

  • ●     SeeWhat is the most important information I should know about gabapentin?
  • ●     The most common side effects of gabapentin include:




  • ●     Store gabapentin tablets between 59to 86(15to 30


















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Gabapentin

Gabapentin

Gabapentin

Gabapentin TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-367(NDC:0228-2636)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GABAPENTIN GABAPENTIN 600 mg

Inactive Ingredients

Ingredient Name Strength
CALCIUM STEARATE
CROSPOVIDONE
hydroxypropyl cellulose
polyethylene glycol
titanium dioxide
FERRIC OXIDE YELLOW
FD&C BLUE NO. 2
HYPROMELLOSES

Product Characteristics

Color Size Imprint Code Shape
green 15 mm R;636 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-367-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075694 2011-07-11


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.